IP Verse

Pharmaceutical Composition For Cancer Treatment

Patent No. EP3616720 (titled "Pharmaceutical Composition For Cancer Treatment") was filed by Osaka University on Mar 28, 2018. The application was issued on Feb 17, 2021.

Patent Summary

Antitumor antibody that inhibits immunosuppression mediated by Treg cells or the like. The antibody decreases the cell counts of the tumor-infiltrating Treg cells and the tumor-infiltrating macrophage cells and inhibits tumor growth.

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEVERS & ORESNov 17, 2021GEVERS PATENTS
GLAXOSMITHKLINENov 17, 2021KIM
JAMES POOLENov 17, 2021CARPMAELS & RANSFORD
POHLMANNov 17, 2021POHLMAN
SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBNov 17, 2021SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB
ABBVIENov 16, 2021WILDING
J A KEMPNov 16, 2021J A KEMP
PARK GROVENov 16, 2021SNODIN
STRAWMANNov 15, 2021D YOUNG
KONIG SZYNKA TILMANN VON RENESSEOct 14, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSEOct 14, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3616720

OSAKA UNIVERSITY
Application Number
EP19202367A
Filing Date
Mar 28, 2018
Status
Revoked
Aug 15, 2025
Publication Date
Feb 17, 2021
External Links
Slate, Register , Google Patents